QA: Neurogene Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001404644_2019_Neurogene_Inc.pdf

Logs

Graph

Absolute values for 0001404644, Neurogene Inc

  xvar xval
0 AssetsCurrent 77,165,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 400,000
3 remainder_Assets 53,000
4 LiabilitiesCurrent 4,627,000
5 LiabilitiesNoncurrent 319,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,005,711
9 ResearchAndDevelopmentExpense 42,627,446
10 remainder_Expenses 0
11 remainder_Revenues 25,000,000
12 remainder_NetIncome 1,035,672
13 remainder_ComprehensiveNetIncome 79,914
  yvar yval
0 Assets 77,618,000
1 Liabilities 4,946,000
2 Expenses 59,633,157
3 Revenues 25,000,000
4 StockholdersEquity 72,672,000
5 NetIncome -33,597,485
6 ComprehensiveNetIncome -33,557,528
7 BaseVar 84,156,372
8 EconomicCapitalRatiobeforeLimitedLiability 3.02
9 EconomicCapitalRatio 3.70

Edgar->Model Mapping

Feature Distribution

Change over Time